Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Innovative EyewearLUCY -6.57%61 EPS without NRI is $-1.69 as of Mar. 2026. GuruFocus rates LUCY with a GF Score™ of 61/100 and a GF Value™ of $1.80 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 662 Medical Devices & Instruments companies, Innovative Eyewear ranks better than 89.73% on this metric.
Innovative Eyewear's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was $-0.37.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.69.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 52.20% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 4.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Innovative Eyewear's EPS without NRI or its related term are showing as below:
LUCY'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -263.9 Med: -33.7 Max: 52.2
Current: 52.2
During the past 7 years, Innovative Eyewear's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 52.20% per year. The lowest was -263.90% per year. And the median was -33.70% per year.
LUCY's 3-Year EPS without NRI Growth Rate is ranked better than 89.73% of 662
companies
in the Medical Devices & Instruments industry
Industry Median: 8.15
vs LUCY: 52.20
Innovative Eyewear's EPS (Basic) for the
three
months ended in Mar. 2026 was $-0.37.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.69.
Innovative Eyewear (NAS:LUCY) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Innovative Eyewear EPS without NRI Related Terms
Innovative Eyewear EPS without NRI Historical Data
* Premium members only.
The historical data trend for Innovative Eyewear's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LUCY vs NXGL, CBSC, RSCF: EPS without NRI Comparison
For the Medical Instruments & Supplies subindustry, Innovative Eyewear's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innovative Eyewear PE Ratio without NRI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Innovative Eyewear's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Innovative Eyewear's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.69
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innovative Eyewear (LUCY) has a EPS without NRI of $-1.69 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Innovative Eyewear and its competitors. According to the industry distribution chart, Innovative Eyewear ranks #68 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 10.3%.
Is Innovative Eyewear's EPS without NRI too high?
Innovative Eyewear's current EPS without NRI is $-1.69. Based on the distribution chart, Innovative Eyewear ranks #68 out of 662 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Innovative Eyewear has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Innovative Eyewear's EPS without NRI compare to NXGL and CBSC?
According to the Medical Devices & Instruments industry distribution chart, Innovative Eyewear ranks #68 out of 662 companies for EPS without NRI. This places Innovative Eyewear in the top 10% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Innovative Eyewear and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovative Eyewear's current EPS without NRI is $-1.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovative Eyewear stock overvalued right now?
Based on GuruFocus' analysis, Innovative Eyewear (LUCY) is currently considered Possible Value Trap. The stock's GF Value™ is $1.80, compared to a current price of $0.95 — trading 47% below its estimated fair value. The current EPS without NRI is $-1.69. Innovative Eyewear's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Innovative Eyewear (LUCY), the current EPS without NRI is $-1.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Innovative Eyewear (LUCY) Overvalued in 2026?
Based on GuruFocus' analysis, Innovative Eyewear stock appears to be undervalued.
The current stock price of $0.95 is trading 47% below its estimated GF Value™ of $1.80.
GuruFocus considers Innovative Eyewear to be Possible Value Trap.
Key valuation signals for LUCY:
EPS without NRI: $-1.69
GF Value™: $1.80 vs. price of $0.95 (47% below fair value)
No single metric tells the full story. See the LUCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.
61GF Score
Get the complete analysis for LUCY
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUCY has been successfully added to your 
